Therapeutics and discovery track
For techbio companies, partnering with big pharma can be a key goal, either as the endgame, or as a step along the path to success. However, these organisations can be opaque to outsiders, and it may not be obvious what they are looking for in a partner. Our panel will help us unpack this so that you can better strategise your approach.